DR1 and cancer: Further we compare LOCATOR’s NC2 patient subgroups with the PDL1 immunoregulatory protein score published by Keren et al. In the original study by Keren et al. higher PDL1 score levels are associated with poorer survival, mixed tissue type, and cancer progression.